More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin

In conclusion, the anti-leukemic activity of ATG, particularly CDC, is more potent for ALL than AML in vitro. If this applies in vivo, ATG-based GVHD prophylaxis may be particularly advantageous for ALL.
Source: Cytotherapy - Category: Cytology Source Type: research